IL16
Basic information
Region (hg38): 15:81159575-81314058
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the IL16 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 6 | |||||
missense | 71 | 78 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 6 | |||||
Total | 0 | 0 | 76 | 7 | 7 |
Variants in IL16
This is a list of pathogenic ClinVar variants found in the IL16 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
15-81225407-C-T | not specified | Uncertain significance (Oct 02, 2023) | ||
15-81225418-G-A | not specified | Likely benign (Oct 03, 2022) | ||
15-81225422-G-C | not specified | Uncertain significance (Jan 23, 2024) | ||
15-81225428-G-T | not specified | Uncertain significance (Jul 12, 2022) | ||
15-81225454-A-G | not specified | Uncertain significance (Mar 31, 2024) | ||
15-81225572-A-C | not specified | Uncertain significance (Jun 11, 2021) | ||
15-81225691-A-G | not specified | Uncertain significance (Feb 27, 2024) | ||
15-81259781-A-G | not specified | Uncertain significance (Jun 07, 2024) | ||
15-81259782-C-T | not specified | Uncertain significance (May 14, 2024) | ||
15-81259803-C-G | not specified | Uncertain significance (Jun 03, 2024) | ||
15-81259872-A-T | not specified | Uncertain significance (May 31, 2023) | ||
15-81265725-A-G | not specified | Uncertain significance (Dec 06, 2023) | ||
15-81265778-G-A | not specified | Uncertain significance (Nov 06, 2023) | ||
15-81269557-G-A | not specified | Uncertain significance (Sep 15, 2021) | ||
15-81269580-G-A | not specified | Uncertain significance (Oct 25, 2023) | ||
15-81269590-C-A | not specified | Uncertain significance (Feb 28, 2023) | ||
15-81273108-G-A | not specified | Uncertain significance (Feb 15, 2023) | ||
15-81273135-C-T | not specified | Uncertain significance (Mar 28, 2024) | ||
15-81273175-C-A | not specified | Uncertain significance (Jan 04, 2022) | ||
15-81273186-G-T | not specified | Uncertain significance (Aug 12, 2021) | ||
15-81278849-A-G | not specified | Uncertain significance (Feb 13, 2024) | ||
15-81279565-A-G | not specified | Uncertain significance (Mar 25, 2024) | ||
15-81279573-C-T | not specified | Uncertain significance (Aug 02, 2023) | ||
15-81279598-G-A | not specified | Uncertain significance (Aug 28, 2023) | ||
15-81279604-C-T | not specified | Likely benign (Jul 20, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
IL16 | protein_coding | protein_coding | ENST00000302987 | 18 | 153189 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.24e-10 | 1.00 | 125636 | 1 | 111 | 125748 | 0.000445 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.700 | 697 | 751 | 0.928 | 0.0000422 | 8592 |
Missense in Polyphen | 204 | 242.58 | 0.84097 | 2760 | ||
Synonymous | -0.843 | 330 | 311 | 1.06 | 0.0000186 | 2826 |
Loss of Function | 3.35 | 25 | 50.8 | 0.492 | 0.00000271 | 604 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000964 | 0.000935 |
Ashkenazi Jewish | 0.000412 | 0.000397 |
East Asian | 0.000334 | 0.000326 |
Finnish | 0.000324 | 0.000323 |
European (Non-Finnish) | 0.000355 | 0.000352 |
Middle Eastern | 0.000334 | 0.000326 |
South Asian | 0.00108 | 0.00105 |
Other | 0.000173 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Interleukin-16 stimulates a migratory response in CD4+ lymphocytes, monocytes, and eosinophils. Primes CD4+ T-cells for IL-2 and IL-15 responsiveness. Also induces T-lymphocyte expression of interleukin 2 receptor. Ligand for CD4.; FUNCTION: Isoform 3 is involved in cell cycle progression in T- cells. Appears to be involved in transcriptional regulation of SKP2 and is probably part of a transcriptional repression complex on the core promoter of the SKP2 gene. May act as a scaffold for GABPB1 (the DNA-binding subunit the GABP transcription factor complex) and HDAC3 thus maintaining transcriptional repression and blocking cell cycle progression in resting T-cells.;
- Pathway
- Other interleukin signaling;Signaling by Interleukins;Cytokine Signaling in Immune system;JAK STAT MolecularVariation 1;GPCR signaling-G alpha q;GPCR signaling-cholera toxin;GPCR signaling-pertussis toxin;Immune System;GPCR signaling-G alpha s Epac and ERK;GPCR signaling-G alpha s PKA and ERK;JAK STAT pathway and regulation;GPCR signaling-G alpha i
(Consensus)
Recessive Scores
- pRec
- 0.192
Intolerance Scores
- loftool
- 0.717
- rvis_EVS
- -0.07
- rvis_percentile_EVS
- 47.8
Haploinsufficiency Scores
- pHI
- 0.108
- hipred
- N
- hipred_score
- 0.420
- ghis
- 0.566
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.948
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Il16
- Phenotype
- immune system phenotype; hematopoietic system phenotype;
Gene ontology
- Biological process
- immune response;regulation of signaling receptor activity;viral process;cytokine-mediated signaling pathway;leukocyte chemotaxis;induction of positive chemotaxis;regulation of calcium ion transport
- Cellular component
- extracellular region;extracellular space;cytosol;plasma membrane;nuclear speck
- Molecular function
- cytokine activity;CD4 receptor binding